Tag Archives: wegovy

Wegovy Novo Nordisk has announced that they are no longer able to meet the demand in the US marketplace for Wegovy. To ensure people on Wegovy can get their medication, they are prioritizing access to the highest strengths (1.7 mg and 2.4 mg), and will be only producing limited amounts of the starting strengths (.25 […]

Semaglutide has been FDA-approved for the treatment of type 2 diabetes in the forms of Ozempic and Rybelsus, and for the treatment of obesity in the form of Wegovy. Tirzepatide has been approved for the treatment of diabetes in the form of Mounjaro. However, many individuals do not have insurance coverage for these medications. We […]

The FDA has approved a very exciting medication called Mounjaro™. Although approved for treatment of type 2 diabetes, a side effect of Mounjaro™ is weight loss. The same molecule, tirzapeptide, is being researched for weight loss as well. Mounjaro™ is the newest in the class of GLP-1 analogues. GLP-1 (glucagon-like peptide 1) is a hormone […]

Updated 3/22/2023 Wegovy Available at Retail Pharmacies Click here to see if you have insurance coverage for Wegovy. There is a lot of interest in developing safe and effective weight loss medications. Right now, we are seeing great results with a class of medications called GLP-1 analogues. GLP-1 stands like “Glucagon like peptide 1.” GLP […]